This report showed that the lack of inflammasome components such as NLRP3 and caspase-1 results in failed activation of IFN-γ-producing CD8+ T cells, indicating that inflammasome activation makes anti-cancer chemotherapy against tumors more efficient. The gene discussed is IFNG; the disease is cancer.